Treatment of hypoxia‐dependent cardiovascular diseases by myo‐inositol trispyrophosphate (ITPP)‐enhancement of oxygen delivery by red blood cells

Heart failure is a consequence of progression hypoxia‐dependent tissue damages. Therapeutic approaches to restore and/or protect the healthy cardiac tissue have largely failed and remain a major challenge of regenerative medicine. The myo‐inositol trispyrophosphate (ITPP) is a modifier of haemoglobi...

Descripción completa

Detalles Bibliográficos
Autores principales: Oknińska, Marta, El‐Hafny‐Rahbi, Bouchra, Paterek, Aleksandra, Mackiewicz, Urszula, Crola‐Da Silva, Claire, Brodaczewska, Klaudia, Mączewski, Michał, Kieda, Claudine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011163/
https://www.ncbi.nlm.nih.gov/pubmed/31957267
http://dx.doi.org/10.1111/jcmm.14909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011163/
https://www.ncbi.nlm.nih.gov/pubmed/31957267
http://dx.doi.org/10.1111/jcmm.14909

Ejemplares similares